COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation

COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation

Machine learning (ML) algorithms were used to identify a novel biological target for breast cancer and explored its relationship with the tumor microenvironment (TME) and patient prognosis. The edgR package identified hub genes associated with overall survival (OS) and prognosis, which were validate...

Full description

Bibliographic Details
Main Authors: Wenjie Shi, Zhilin Chen, Hui Liu, Chen Miao, Ruifa Feng, Guilin Wang, Guoping Chen, Zhitong Chen, Pingming Fan, Weiyi Pang, Chen Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
machine learning
COL11A1
breast cancer
tumor microenvironment
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.937125/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.937125/full

Similar Items